logo

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Wayne R Godfrey

This inventor holds 14 USPTO granted patents and 2 EPO patents, primarily in Immunotherapy Techniques. Top assignees: Leland Stanford Junior University, University of Pennsylvania, Becton Dickinson and Company Limited. Active years: 1998-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wayne R Godfrey. Retrieved from https://idiyas.com/inventor/wayne-r-godfrey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14

% Patents Active = 64.3


Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 168(Granted Patents)


Location History:

  • White Bear Lake, MN (US) (2000)
  • Woodside, CA (US) (1998 - 2008)
  • Birchwood, MN (US) (2006 - 2010)
  • Los Altos, CA (US) (2012 - 2016)

Company Filing History:

goldMedal8 out of 5,519 
 
Leland Stanford Junior University
 patents
silverMedal5 out of 2,663 
 
University of Pennsylvania
 patents
bronzeMedal2 out of 5,413 
 
Becton Dickinson and Company Limited
 patents
4. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
T Regulatory Cells
Immunotherapy
Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis
ACT-4
Antibodies
CD4 T-Cells
Ligand Binding
14 patents (USPTO):Explore Patents
1. 9273282 - Methods for the isolation and expansion of cord blood derived T regulatory cells (2016-03-01),
2. 9187727 - Methods for the isolation and expansion of cord blood derived T regulatory cells (2015-11-17),
3. 9181526 - Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses (2015-11-10),
4. 8129185 - Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses (2012-03-06),
5. 7651855 - Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses (2010-01-26),
6. 7364733 - Antibody to receptor on the surface of activated T-cells: ACT-4 (2008-04-29),
7. 7125670 - [object Object] (2006-10-24),
8. 7098184 - Method of treating rheumatoid arthritis and multiple sclerosis diseases of the human immune system (2006-08-29),
9. 6528623 - Antibodies that specifically bind ACT-4-L-h-1 ligand (2003-03-04),
10. 6528055 - Methods of administering antibodies that specifically bind ACT-4-L-h-1 ligand (2003-03-04),
11. 6277962 - Receptor on the surface of activated t-cells: act-4 (2001-08-21),
12. 6242566 - Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells (2001-06-05),
13. 6156878 - Ligand (ACT-4-L) to a receptor on the surface of activated CD4.sup.+ (2000-12-05),
14. 5821332 - Receptor on the surface of activated CD4.sup.+ T-cells: ACT-4 (1998-10-13),

Title: Wayne R Godfrey: Innovator in Cord Blood Research

Introduction

Wayne R Godfrey is a prominent inventor based in Los Altos, CA (US). He has made significant contributions to the field of medical research, particularly in the area of cord blood-derived T regulatory cells. With a total of 14 patents to his name, Godfrey's work has the potential to impact therapeutic approaches in immunology.

Latest Patents

One of his latest patents is titled "Methods for the isolation and expansion of cord blood derived T regulatory cells." This invention encompasses methods and kits for the isolation and expansion of T regulatory cells that have the CD45RA phenotype, including such cells derived from human umbilical cord blood. This innovative approach aims to enhance the availability of these crucial cells for research and therapeutic applications.

Career Highlights

Throughout his career, Wayne R Godfrey has worked with esteemed institutions such as Leland Stanford Junior University and the University of Pennsylvania. His research has focused on advancing the understanding and application of T regulatory cells in various medical contexts.

Collaborations

Some of his notable coworkers include Edgar George Engleman and Carl H June. Their collaborative efforts have contributed to the advancement of research in immunology and cell therapy.

Conclusion

Wayne R Godfrey's innovative work in the field of cord blood research exemplifies the impact of dedicated inventors in advancing medical science. His contributions continue to pave the way for new therapeutic possibilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…